Armen Shanafelt - Insider Trading & Ownership

Entity
Individual
Location
C/O Lilly Ventures Fund I, Llc, 115 W. Washington Street,Ste 1680 South, Indianapolis, IN
All Insider Reports
All Insider Reports

Ownership of Armen Shanafelt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SYRE Spyre Therapeutics, Inc. Director Jun 7, 2022
SURF Surface Oncology, Inc. Director, 10%+ Owner Jun 8, 2022

Insider Transactions Reported by Armen Shanafelt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.